Ensuring the purity and safety of pharmaceutical products is a critical aspect of drug development and manufacturing. Impurities in drugs, whether from synthesis, degradation, or contamination, can have profound implications for patient health. Mass spectrometry has emerged as a powerful analytical technique for detecting and characterizing these impurities, but the complexity of traditional mass spectrometry systems has posed challenges for routine drug impurity testing, especially for quality control (QC) laboratories.
read more